Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "G04BD" (76)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Drugs for Urinary Frequency and Incontinence (G04BD) 3 products
WHO-DDD
IP
CI
Ph
Granufink Blase
50 Capsule(s)
PR
PR
k.A.
Capsules: 2 Active Agents
Perrigo Schweiz AG
D
FB
G
IP
CI
Ph
Granufink Blase
100 Capsule(s)
PR
PR
k.A.
Capsules: 2 Active Agents
Perrigo Schweiz AG
D
FB
G
IP
CI
Ph
Granufink Blase
160 Capsule(s)
PR
PR
k.A.
Capsules: 2 Active Agents
Perrigo Schweiz AG
D
FB
G
Flavoxate (G04BD02) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Urispas
30 Tablet(s)
6.93
16.75
10 %
Coated tablets: Flavoxati Hydrochloridum 200 mg
Recordati AG
B / SL
FB
G
IP
CI
Urispas
100 Tablet(s)
19.63
37.75
10 %
Coated tablets: Flavoxati Hydrochloridum 200 mg
Recordati AG
B / SL
FB
G
Oxybutynin (G04BD04) 5 products
WHO-DDD
DrugBank.ca
L
IP
CI
Vesoxx 1 mg/ml
100
1107.22
1220.60
10 %
Lösung zur Intravesikalen Anwendung: Oxybutynini Hydrochloridum 1.004 mg/ml
Melisana AG
B / SL
FB
G
IP
CI
Velariq 1 mg/ml
12 x 10 ml
PR
PR
k.A.
Salmon Pharma GmbH
B
FB
G
IP
CI
Velariq 1 mg/ml
96 x 10 ml
PR
PR
k.A.
Salmon Pharma GmbH
B
FB
G
IP
CI
Kentera
8 plaster(s)
28.70
47.65
10 %
Transdermal patch: Oxybutyninum 36 mg
Teva Pharma AG
B / SL
FB
G
IP
CI
Vesoxx 1 mg/ml
100
1107.22
1220.60
k.A.
Lösung zur Intravesikalen Anwendung: Oxybutynini Hydrochloridum 1.004 mg/ml
Melisana AG
B
FB
G
Propiverine (G04BD06) 9 products
WHO-DDD
L
IP
CI
Mictonet 5 mg
56
10.17
27.50
10 %
Dragées: Propiverini Hydrochloridum 5 mg
Labatec Pharma SA
B / SL
FB
G
L
IP
CI
Mictonet 5 mg
28
5.78
15.50
10 %
Dragées: Propiverini Hydrochloridum 5 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Mictonorm 30 mg
28
22.93
41.35
10 %
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Mictonorm 30 mg
84
58.47
80.00
10 %
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B / SL
FB
G
L
IP
CI
Mictonorm 45 mg
28
27.52
46.35
10 %
Gélules à libération modifiée: Propiverini Hydrochloridum 45 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Mictonet 5 mg
7
PR
PR
k.A.
Dragées: Propiverini Hydrochloridum 5 mg
Labatec Pharma SA
B
FB
G
IP
CI
Mictonorm 30 mg
7
PR
PR
k.A.
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B
FB
G
IP
CI
Mictonorm 45 mg
7
PR
PR
k.A.
Gélules à libération modifiée: Propiverini Hydrochloridum 45 mg
Labatec Pharma SA
B
FB
G
IP
CI
Mictonorm 45 mg
84
PR
PR
k.A.
Gélules à libération modifiée: Propiverini Hydrochloridum 45 mg
Labatec Pharma SA
B
FB
G
Tolterodine (G04BD07) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Detrusitol SR 4 mg
-
T
14 Capsule(s)
11.37
28.80
10 %
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Detrusitol SR 4 mg
-
T
56 Capsule(s)
45.44
65.85
10 %
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Detrusitol SR 2 mg
28 Capsule(s)
PR
73.25
k.A.
Delayed release capsules: Tolterodini Tartras 2 mg
Viatris Pharma GmbH
B
FB
G
Solifenacin (G04BD08) 22 products
WHO-DDD
DrugBank.ca
SIP
IP
CI
Vesicare 5 mg
-
T
30 Tablet(s)
22.90
41.00
20 %
Coated tablets: Solifenacini Succinas 5 mg
Astellas Pharma AG
B / SL / SO
FB
G
SIP
IP
CI
Vesicare 5 mg
-
T
90 Tablet(s)
63.87
85.10
20 %
Coated tablets: Solifenacini Succinas 5 mg
Astellas Pharma AG
B / SL / SO
FB
G
SIP
IP
CI
Vesicare 10 mg
30 Tablet(s)
27.36
45.80
20 %
Coated tablets: Solifenacini Succinas 10 mg
Astellas Pharma AG
B / SL / SO
FB
G
SIP
IP
CI
Vesicare 10 mg
90 Tablet(s)
76.34
98.50
20 %
Coated tablets: Solifenacini Succinas 10 mg
Astellas Pharma AG
B / SL / SO
FB
G
IP
CI
Solifenacin NOBEL 5 mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
IP
CI
Solifenacin NOBEL 5 mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
NOBEL Pharma Schweiz AG
●
B / SL / SG
FB
G
IP
Solifenacin NOBEL 10 mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
IP
Solifenacin NOBEL 10 mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
IP
CI
Solifenacin Sandoz 5 mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Solifenacin Sandoz 5 mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Solifenacin Sandoz 10 mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Solifenacin Sandoz 10 mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Solifenacin Spirig HC 5 mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Solifenacin Spirig HC 5 mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
Solifenacin Spirig HC 10 mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Solifenacin Spirig HC 10 mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Solifenacin-Mepha 5mg
100
55.49
76.50
10 %
Coated tablets: Solifenacini Succinas 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
Solifenacin-Mepha, 10mg
100
66.32
88.20
10 %
Coated tablets: Solifenacini Succinas 10 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
Trospium (G04BD09) 6 products
WHO-DDD
DrugBank.ca
IP
CI
Spasmo-Urgenin Neo
-
T
20 Dragée(s)
6.75
16.60
10 %
Dragées: Trospii Chloridum 20 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Spasmo-Urgenin Neo
-
T
60 Dragée(s)
17.43
35.35
10 %
Dragées: Trospii Chloridum 20 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Spasmex 20 mg
30
10.81
28.15
10 %
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B / SL
FB
G
IP
CI
Spasmex 20 mg
100
33.26
52.60
10 %
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B / SL
FB
G
IP
CI
Spasmex 20 mg
50
PR
PR
k.A.
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B
FB
G
IP
CI
Spasmex 20 mg
10 x 50
PR
PR
k.A.
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B
FB
G
Darifenacin (G04BD10) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Emselex 7.5 mg
-
T
14 Tablet(s)
10.20
27.50
10 %
Delayed release tablets: Darifenacinum 7.5 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Emselex 7.5 mg
-
T
56 Tablet(s)
40.77
60.75
10 %
Delayed release tablets: Darifenacinum 7.5 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Emselex 15 mg
-
T
14 Tablet(s)
10.20
27.50
10 %
Delayed release tablets: Darifenacinum 15 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Emselex 15 mg
-
T
56 Tablet(s)
40.77
60.75
10 %
Delayed release tablets: Darifenacinum 15 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
Fesoterodine (G04BD11) 16 products
WHO-DDD
DrugBank.ca
IP
CI
Fesoterodin Spirig HC
retard 4 mg
14
9.02
26.25
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Fesoterodin Spirig HC
retard 4 mg
84
52.66
73.70
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Fesoterodin Spirig HC
retard 8 mg
14
9.45
26.70
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Fesoterodin Spirig HC
retard 8 mg
84
55.38
76.65
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Spirig HealthCare AG
B / SL / SG
FB
G
SIP
IP
CI
Toviaz, Retardtabletten 4 mg
14 Tablet(s)
9.92
27.15
10 %
Fesoterodini Fumaras 4 mg
Pfizer AG
B / SL / SO
FB
G
SIP
IP
CI
Toviaz, Retardtabletten 4 mg
84 Tablet(s)
57.92
79.10
10 %
Fesoterodini Fumaras 4 mg
Pfizer AG
B / SL / SO
FB
G
SIP
IP
CI
Toviaz, Retardtabletten 8 mg
-
T
14 Tablet(s)
10.39
27.65
10 %
Fesoterodini Fumaras 8 mg
Pfizer AG
B / SL / SO
FB
G
SIP
IP
CI
Toviaz, Retardtabletten 8 mg
-
T
84 Tablet(s)
60.91
82.30
10 %
Fesoterodini Fumaras 8 mg
Pfizer AG
B / SL / SO
FB
G
IP
CI
Fesoterodin Zentiva 4 mg
14
9.02
26.25
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Fesoterodin Zentiva 4 mg
84
52.66
73.70
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Fesoterodin Zentiva 8 mg
14
9.45
26.70
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Helvepharm AG
B / SL / SG
FB
G
IP
Fesoterodin Zentiva 8 mg
84
55.38
76.65
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Fesoterodin-Mepha 4 mg
14
9.02
26.25
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Fesoterodin-Mepha 4 mg
84
52.66
73.70
10 %
Delayed release tablets: Fesoterodini Fumaras 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Fesoterodin-Mepha 8 mg
14
9.45
26.70
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Fesoterodin-Mepha 8 mg
84
55.38
76.65
10 %
Delayed release tablets: Fesoterodini Fumaras 8 mg
Mepha Pharma AG
B / SL / SG
FB
G
Mirabegron (G04BD12) 6 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Betmiga 25 mg
30 Tablet(s)
34.22
53.65
10 %
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 25 mg
90 Tablet(s)
100.72
125.95
10 %
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 50 mg
30 Tablet(s)
34.22
53.65
10 %
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 50 mg
90 Tablet(s)
100.72
125.95
10 %
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B / SL
FB
G
IP
CI
PP
Betmiga 25 mg
10 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Mirabegronum 25 mg
Astellas Pharma AG
B
FB
G
IP
CI
PP
Betmiga 50 mg
10 Tablet(s)
PR
PR
k.A.
Delayed release tablets: Mirabegronum 50 mg
Astellas Pharma AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
